Cargando…

Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)

Objectives: The study aimed to evaluate biomarkers facilitating early axial-spondyloarthritis (axSpA) diagnosis and disease activity and imaging indices correlated. Materials and Methods: Seventy-five patients with low back pain (LBP) (≥3 months, ≤2 years, onset ≤45 years) participating in the Itali...

Descripción completa

Detalles Bibliográficos
Autores principales: Lorenzin, Mariagrazia, Ortolan, Augusta, Felicetti, Mara, Favero, Marta, Vio, Stefania, Zaninotto, Martina, Polito, Pamela, Cosma, Chiara, Scapin, Vanna, Lacognata, Carmelo, Ramonda, Roberta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692922/
https://www.ncbi.nlm.nih.gov/pubmed/31440510
http://dx.doi.org/10.3389/fmed.2019.00177
_version_ 1783443615101485056
author Lorenzin, Mariagrazia
Ortolan, Augusta
Felicetti, Mara
Favero, Marta
Vio, Stefania
Zaninotto, Martina
Polito, Pamela
Cosma, Chiara
Scapin, Vanna
Lacognata, Carmelo
Ramonda, Roberta
author_facet Lorenzin, Mariagrazia
Ortolan, Augusta
Felicetti, Mara
Favero, Marta
Vio, Stefania
Zaninotto, Martina
Polito, Pamela
Cosma, Chiara
Scapin, Vanna
Lacognata, Carmelo
Ramonda, Roberta
author_sort Lorenzin, Mariagrazia
collection PubMed
description Objectives: The study aimed to evaluate biomarkers facilitating early axial-spondyloarthritis (axSpA) diagnosis and disease activity and imaging indices correlated. Materials and Methods: Seventy-five patients with low back pain (LBP) (≥3 months, ≤2 years, onset ≤45 years) participating in the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) study underwent a physical examination, questionnaires, laboratory tests, spine, and sacroiliac joints (SIJ) X-rays and magnetic resonance imaging (MRI) at baseline and during a 24-months follow-up. Two expert rheumatologists formulated axSpA diagnosis and assessed fulfillment of Assessment of SpondyloArthritis International Society (ASAS) criteria. Disease activity and physical functioning were assessed using imaging, clinical, and serological indices. Spine and SIJ MRI and X-rays were scored independently by 2 readers following the Spondyloarthritis Research Consortium of Canada (SPARCC), mSASSS, and mNY-criteria. Patients were classified in accordance to ASAS criteria as: 21 patients classified according to axSpA imaging arm; 29 patients classified according to axSpA clinical ± imaging arm; 25 patients not fulfilling ASAS criteria. Results: At baseline biomarker levels were not significantly increased in any of the patient groups. Instead, a significant decrease of all functional and disease activity indices from baseline to 24 months was observed in all the three groups. In the same period, there were no significant variation in the serological markers values within each group. The correlations between IL-17 and IL-23 and clinical and functional indices were not significant. On the other hand, significant correlations were found between IL-22 and Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Patient Global Score (BASG1), Health Assessment Questionnaire (HAQ), Visual Analog Scale (VAS pain); MMP3 and mSASSS; MMP3 and hsCRP. Conclusions: Although not significantly higher in any of the cohorts, IL-22, MMP3, and hsCRP values correlated with some disease activity indices and with mSASSS. Further studies are warranted to confirm these preliminary findings.
format Online
Article
Text
id pubmed-6692922
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66929222019-08-22 Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study) Lorenzin, Mariagrazia Ortolan, Augusta Felicetti, Mara Favero, Marta Vio, Stefania Zaninotto, Martina Polito, Pamela Cosma, Chiara Scapin, Vanna Lacognata, Carmelo Ramonda, Roberta Front Med (Lausanne) Medicine Objectives: The study aimed to evaluate biomarkers facilitating early axial-spondyloarthritis (axSpA) diagnosis and disease activity and imaging indices correlated. Materials and Methods: Seventy-five patients with low back pain (LBP) (≥3 months, ≤2 years, onset ≤45 years) participating in the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) study underwent a physical examination, questionnaires, laboratory tests, spine, and sacroiliac joints (SIJ) X-rays and magnetic resonance imaging (MRI) at baseline and during a 24-months follow-up. Two expert rheumatologists formulated axSpA diagnosis and assessed fulfillment of Assessment of SpondyloArthritis International Society (ASAS) criteria. Disease activity and physical functioning were assessed using imaging, clinical, and serological indices. Spine and SIJ MRI and X-rays were scored independently by 2 readers following the Spondyloarthritis Research Consortium of Canada (SPARCC), mSASSS, and mNY-criteria. Patients were classified in accordance to ASAS criteria as: 21 patients classified according to axSpA imaging arm; 29 patients classified according to axSpA clinical ± imaging arm; 25 patients not fulfilling ASAS criteria. Results: At baseline biomarker levels were not significantly increased in any of the patient groups. Instead, a significant decrease of all functional and disease activity indices from baseline to 24 months was observed in all the three groups. In the same period, there were no significant variation in the serological markers values within each group. The correlations between IL-17 and IL-23 and clinical and functional indices were not significant. On the other hand, significant correlations were found between IL-22 and Bath Ankylosing Spondylitis Functional Index (BASFI), Bath Ankylosing Spondylitis Patient Global Score (BASG1), Health Assessment Questionnaire (HAQ), Visual Analog Scale (VAS pain); MMP3 and mSASSS; MMP3 and hsCRP. Conclusions: Although not significantly higher in any of the cohorts, IL-22, MMP3, and hsCRP values correlated with some disease activity indices and with mSASSS. Further studies are warranted to confirm these preliminary findings. Frontiers Media S.A. 2019-08-07 /pmc/articles/PMC6692922/ /pubmed/31440510 http://dx.doi.org/10.3389/fmed.2019.00177 Text en Copyright © 2019 Lorenzin, Ortolan, Felicetti, Favero, Vio, Zaninotto, Polito, Cosma, Scapin, Lacognata and Ramonda. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Lorenzin, Mariagrazia
Ortolan, Augusta
Felicetti, Mara
Favero, Marta
Vio, Stefania
Zaninotto, Martina
Polito, Pamela
Cosma, Chiara
Scapin, Vanna
Lacognata, Carmelo
Ramonda, Roberta
Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
title Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
title_full Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
title_fullStr Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
title_full_unstemmed Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
title_short Serological Biomarkers in Early Axial Spondyloarthritis During 24-Months Follow Up (Italian Arm of Space Study)
title_sort serological biomarkers in early axial spondyloarthritis during 24-months follow up (italian arm of space study)
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692922/
https://www.ncbi.nlm.nih.gov/pubmed/31440510
http://dx.doi.org/10.3389/fmed.2019.00177
work_keys_str_mv AT lorenzinmariagrazia serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT ortolanaugusta serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT felicettimara serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT faveromarta serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT viostefania serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT zaninottomartina serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT politopamela serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT cosmachiara serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT scapinvanna serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT lacognatacarmelo serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy
AT ramondaroberta serologicalbiomarkersinearlyaxialspondyloarthritisduring24monthsfollowupitalianarmofspacestudy